Detalhe da pesquisa
1.
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.
Cell
; 184(16): 4203-4219.e32, 2021 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34242577
2.
Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies.
Cell
; 184(11): 2955-2972.e25, 2021 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34019795
3.
The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination.
Nat Immunol
; 22(10): 1294-1305, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34556879
4.
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody.
Cell
; 165(2): 449-63, 2016 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26949186
5.
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice.
Immunity
; 53(4): 724-732.e7, 2020 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32783919
6.
Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses.
Nature
; 594(7864): 553-559, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33971664
7.
Identification of CDRH3 loops in the B cell receptor repertoire that can be engaged by candidate immunogens.
PLoS Pathog
; 19(5): e1011401, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37196027
8.
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth.
Immunity
; 45(5): 1108-1121, 2016 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27851912
9.
Structure-Based Stabilization of SOSIP Env Enhances Recombinant Ectodomain Durability and Yield.
J Virol
; 97(1): e0167322, 2023 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36633409
10.
COVID-19 Diagnosis and SARS-CoV-2 Strain Identification by a Rapid, Multiplexed, Point-of-Care Antibody Microarray.
Anal Chem
; 95(13): 5610-5617, 2023 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36961989
11.
Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved.
Immunity
; 41(6): 909-18, 2014 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25526306
12.
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination.
Nature
; 543(7644): 248-251, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28151488
13.
Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2.
Immunity
; 38(1): 176-86, 2013 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23313589
14.
Star nanoparticles delivering HIV-1 peptide minimal immunogens elicit near-native envelope antibody responses in nonhuman primates.
PLoS Biol
; 17(6): e3000328, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31206510
15.
Antigenicity and Immunogenicity of HIV-1 Envelope Trimers Complexed to a Small-Molecule Viral Entry Inhibitor.
J Virol
; 94(21)2020 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32817216
16.
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC.
J Virol
; 93(3)2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30429340
17.
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost.
J Virol
; 93(3)2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30429343
18.
HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and Phagocytosis.
J Virol
; 92(7)2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29321320
19.
Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates.
J Virol
; 92(8)2018 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29437967
20.
Immunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized Mice.
J Immunol
; 198(3): 1047-1055, 2017 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28011932